Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 88

1.

Protective immunity provided by a new modified SERA protein peptide: its immunogenetic characteristics and correlation with 3D structure.

Bermúdez A, Moreno-Vranich A, Patarroyo ME.

Amino Acids. 2012 Jul;43(1):183-94. doi: 10.1007/s00726-011-1061-5.

PMID:
21894529
2.

Emerging rules for subunit-based, multiantigenic, multistage chemically synthesized vaccines.

Patarroyo ME, Patarroyo MA.

Acc Chem Res. 2008 Mar;41(3):377-86. doi: 10.1021/ar700120t. Review.

PMID:
18266328
3.

HLA-DR allele reading register shifting is associated with immunity induced by SERA peptide analogues.

Salazar LM, Bermúdez A, Patarroyo ME.

Biochem Biophys Res Commun. 2008 Jul 18;372(1):114-20. doi: 10.1016/j.bbrc.2008.04.186.

PMID:
18482577
5.

Fitting modified HRP-I peptide analogue 3D structure into HLA-DR molecules induces protection against Plasmodium falciparum malaria.

Bermúdez A, Alba P, Espejo F, Vargas LE, Parra C, Rodríguez R, Reyes C, Patarroyo ME.

Int J Biochem Cell Biol. 2005 Feb;37(2):336-49.

PMID:
15474979
6.

Peptides inducing short-lived antibody responses against Plasmodium falciparum malaria have shorter structures and are read in a different MHC II functional register.

Patarroyo ME, Alba MP, Vargas LE, Silva Y, Rosas J, Rodríguez R.

Biochemistry. 2005 May 10;44(18):6745-54.

PMID:
15865420
7.

Shortening and modifying the 1513 MSP-1 peptide's alpha-helical region induces protection against malaria.

Espejo F, Bermúdez A, Torres E, Urquiza M, Rodríguez R, López Y, Patarroyo ME.

Biochem Biophys Res Commun. 2004 Mar 5;315(2):418-27.

PMID:
14766224
8.

Structural characterisation of sporozoite components for a multistage, multi-epitope, anti-malarial vaccine.

Patarroyo ME, Cifuentes G, Rodríguez R.

Int J Biochem Cell Biol. 2008;40(3):543-57.

PMID:
17997122
9.

A pre-PEXEL histidine-rich protein II erythrocyte binding peptide as a new way for anti-malarial vaccine development.

Cifuentes G, Patarroyo ME, Reyes C, Córtes J, Patarroyo MA.

Biochem Biophys Res Commun. 2007 Aug 17;360(1):149-55.

PMID:
17588541
10.

Induction and displacement of an helix in the 6725 SERA peptide analogue confers protection against P. falciparum malaria.

Alba MP, Salazar LM, Purmova J, Vanegas M, Rodriguez R, Patarroyo ME.

Vaccine. 2004 Mar 12;22(9-10):1281-9.

PMID:
15003658
13.
14.

Immunogenicity and protectivity of Plasmodium falciparum EBA-175 peptide and its analog is associated with alpha-helical region shortening and displacement.

Bermúdez A, Cifuentes G, Guzmán F, Salazar LM, Patarroyo ME.

Biol Chem. 2003 Oct-Nov;384(10-11):1443-50.

PMID:
14669987
15.

Protective cellular immunity against P. falciparum malaria merozoites is associated with a different P7 and P8 residue orientation in the MHC-peptide-TCR complex.

Patarroyo ME, Salazar LM, Cifuentes G, Lozano JM, Delgado G, Rivera Z, Rosas J, Vargas LE.

Biochimie. 2006 Feb;88(2):219-30.

PMID:
16126320
16.

Protection against experimental P falciparum malaria is associated with short AMA-1 peptide analogue alpha-helical structures.

Cubillos M, Salazar LM, Torres L, Patarroyo ME.

Biochimie. 2002 Dec;84(12):1181-8.

PMID:
12628294
18.
19.

Elongating modified conserved peptides eliminates their immunogenicity and protective efficacy against P. falciparum malaria.

Espejo F, Bermúdez A, Vanegas M, Rivera Z, Torres E, Salazar LM, Patarroyo ME.

J Struct Biol. 2005 Jun;150(3):245-58.

PMID:
15890273
20.

3D structure determination of STARP peptides implicated in P. falciparum invasion of hepatic cells.

Bermúdez A, Alba MP, Vanegas M, Patarroyo ME.

Vaccine. 2010 Jul 12;28(31):4989-96. doi: 10.1016/j.vaccine.2010.05.025.

PMID:
20580741
Items per page

Supplemental Content

Support Center